Logo image
Se connecter
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Article de revue   Avec comité de lecture

Beta-Blocker Interruption or Continuation after Myocardial Infarction

Johanne Silvain, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, Paul Guedeney, Thomas Cuisset, Fabrice Ivanes, Thibault Lhermusier, …
New England Journal of Medicine, Vol.391(14), pp.1277-1286
10/10/2024
PMID: 39213187

Résumé

Aged Female Adrenergic beta-Antagonists Drug Administration Schedule Follow-Up Studies Hospitalization Kaplan-Meier Estimate Myocardial Infarction Quality of Life Stroke Volume Withholding Treatment Secondary Prevention Humans Male Middle Aged
The appropriate duration of treatment with beta-blocker drugs after a myocardial infarction is unknown. Data are needed on the safety and efficacy of the interruption of long-term beta-blocker treatment to reduce side effects and improve quality of life in patients with a history of uncomplicated myocardial infarction.

Fichiers et liens (1)

url
Find in HALAfficher

Détails

Logo image